SR Pharma shares up on drug hopes
13th Nov 2006, 19:40 GMT
LONDON (Reuters) - Shares in SR Pharma hit a four-year high on Monday after promising preclinical results with a product focused on RNAi, a hot area of biotechnology research.
SR Pharma shares up on drug hopes related news:
- Pharma cos view draft policy as bid to nationalise drug sector — NK India News
- Zydus Cadila files drug application to treat obesity — NewKerala Business India News
- Isis Pharma's shares soar on cholesterol-drug Phase II data — MarketWatch.com - Top Stories – Sponsored by: CyberTrader
- Paswan to drug firms: "Have more heart" — Sify.com Finance
- Boston Scientific shares fall on study — Boston.com / News
- Drug stocks pare gains; Solexa, Isis shares soar — MarketWatch.com - Top Stories – Sponsored by: CyberTrader
- Dems Send Drug Stocks Into Withdrawal — RealMoney by TheStreet.com
- Pharma companies slam new draft policy — The Times Of India - India Business
- Vioxx-Like Drug Gets Mixed Reviews — Dayton Daily News National Headlines
- Getting There: Sudden congestion on SR 527 has driver baffled — Seattle Post-Intelligencer: Local News
Latest news from Reuters: Shares:
- FTSE 100 set to edge up
- Playtech to buy Tribeca to join poker top table
- BT applies for long-distance licences in India
- DCC full-year outlook improves
- Wiseman Dairies profits jump
- BHP Billiton venture buys U.S. Gulf acreage
- Dawnay Day Treveria in share placing
- Majestic Wine profit rises
- Shipping broker ACM to float on AIM
- Newspaper round-up